Dawah Pharmaceuticals, Inc.

WILMINGTON, DE · Founded 2017 · CIK 0001738106 · Biotech · Private

pharmaceutical therapeutics and community healthcare delivery platform

dawahpharma.com →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$580K
1 Form D · Oct 2019
84 months since last filing
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$579,998
Form D · SEC

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
2590SIRPANT IMMUNOTHERAPEUTICS INC——
2591SACYL PHARMACEUTICALS, INC.——
2592HELICAL BIOSCIENCES LLC——
2593Dawah Pharmaceuticals, Inc.—$580K
2594Collidion Inc.—$575K
2595Animantis LLC—$550K
2596EVRYS BIO LLC—$548K

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 1 related persons
  • Maksoud MaksoudExecutive Officer

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.